The IGF/IGFBP system in CNS malignancy

Journal of Clinical Pathology - Molecular Pathology

Volumn 54, Issue 4, 2001, Pages 227-229

  Zumkeller, W ^a   Westphal, M ^b  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Brain tumours; Central nervous system; Insulin like growth factor; Insulin like growth factor binding protein

Indexed keywords

MESSENGER RNA; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TUMOR MARKER;

CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID ANALYSIS; CONFERENCE PAPER; GENE TRANSFER; GLIOMA; MEDULLOBLASTOMA; MENINGIOMA; PRIORITY JOURNAL; RNA TRANSCRIPTION; TUMOR REGRESSION;

BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM NEOPLASMS; GENE THERAPY; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; RECEPTOR, IGF TYPE 1; RNA, ANTISENSE; RNA, MESSENGER; SOMATOMEDINS;

EID: 0034907769     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.54.4.227     Document Type: Conference Paper

References (44)

1. The effects of insulin-like growth factors on brain myelination and their potential therapeutic application in myelination disorders
2. Insulin-like growth factors in central nervous system tumors
3. The expression of insulin-like growth factor I and insulin-like growth factor II genes in the human fetal and adult brain and in glioma
4. Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry
5. Radioimmunoassay of insulin-like growth factors I and II in the cerebrospinal fluid of patients with pituitary and other central nervous system tumors
6. Characterization of insulin-like growth factor 1 in human primary brain tumors
7. Insulin-like growth factors (IGF) enhance three-dimensional (3D) growth of human glioblastomas
8. Treatment and prevention of rat glioblastoma by immunogenic C6 cells expressing antisense insulin-like growth factor I RNA
9. Identification of insulin-like growth factor (IGF) and glucose transporter-1 and -3 mRNA in CNS tumors
10. Differential expression of insulin-like growth factor II in human meningiomas
11. A high ratio of insulin-like growth factorII/insulin-like growth factor binding protein 2 messenger RNA as a marker for anaplasia in meningiomas
12. Gene expression of insulin-like growth factor II in human intracranial meningioma
13. IGF-II mRNA expression in LI human glioblastoma cell line parallels cell growth
14. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells
15. Modulation of IGF-2 expression during growth and differentiation of human neuroblastoma cells: Retinoic acid may induce IGF-2
16. Interferon-gamma inhibits DNA synthesis and insulin-like growth factor-II expression in human neuroblastoma cells
17. Suramin disrupts insulin-like growth factor-II (IGF-II) mediated autocrine growth in human SH-SY5Y neuroblastoma cells
18. Immunohistochemical study of insulin-like growth factor II (IGF-II) and insulin-like growth factor binding protein-2 (IGFBP-2) in choroid plexus papilloma
19. Immunocytochemical detection of insulin-like growth factor II (IGF-II) in choroid plexus papilloma: A possible marker for differential diagnosis
20. Genomic imprinting and cancer
21. Variable imprinting of H19 and IGF2 in fetal cerebellum and medulloblastoma
22. IGF2 but not H19 shows loss of imprinting in human glioma
23. Genomic imprinting of IGF2 and H19 in human meningiomas
24. Insulin-like growth factor-I receptors in human glial tumors
25. Expression and synthesis of insulin-like growth factor (IGF)-I, -II and their receptors in human glioma cell lines
26. Expression of two types of receptor for insulin-like growth factors in human malignant glioma
27. Insulin and insulin-like growth factor I in brain tumors: Binding and in vitro effects
28. Enhancement of insulin-like growth factor 2 receptors in glioblastoma
29. Two primitive neuroectodermal tumor cell lines require an activated insulin-like growth factor I receptor for growth in vitro
30. Autocrine secreted insulin-like growth factor-I stimulates MAP kinase-dependent mitogenic effects in human primitive neuro-ectodermal tumor/medulloblastoma
31. Expression of the insulin-like growth factor I receptor C terminus as a myristylated protein leads to induction of apoptosis in tumor cells
32. Mutant IGF-I receptors as dominant negatives for growth and transformation
33. Regression of C6 rat brain tumors by cells expressing an antisense insulin-like growth factor I receptor RNA
34. The role of the insulin-like growth factor I receptor in transformation and apoptosis
35. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia
36. Concentrations of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3), IGF, and IGFBP-3 protease activity in cerebrospinal fluid of children with leukemia, central nervous system tumor, or meningitis
37. Production of insulin-like growth factor-binding proteins by human central nervous system tumors
38. Insulin-like growth factor (IGF)-I, -II and IGF-binding proteins in the cyst fluid of a patient with astrocytoma
39. Expression and synthesis of insulin-like growth factor-binding proteins in human glioma cell lines
40. The IGF/IGFBP system in CNS malignancy
41. Alterations in the synthesis of insulin-like growth factor binding proteins and insulin-like growth factors in rat C6 glioma cells transfected with a gap junction connexin43 cDNA
42. Insulin-like growth factor system in neuroblastoma tumorigenesis and apoptosis: Potential diagnostic and therapeutic perspectives
43. Gene therapy of rat brain glioblastoma by an episome-based transcriptional cassette expressing antisense IGF-I cDNA
44. Gene therapy for malignant neoplasms of the CNS